• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Inari Medical Inc (NQ: NARI )

    54.19 -0.57 (-1.04%)
    Streaming Delayed Price Updated: 2:42 PM EDT, Jul 19, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 353,701
    Open 55.15
    Bid (Size) 54.15 (1)
    Ask (Size) 54.19 (2)
    Prev. Close 54.76
    Today's Range 53.72 - 55.47
    52wk Range 36.81 - 71.85
    Shares Outstanding 54,313,676
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Inari Medical to Announce Second Quarter 2024 Financial Results
    From Inari Medical, Inc.
    Via GlobeNewswire
    Deep Dive Into Inari Medical Stock: Analyst Perspectives (5 Ratings)
    Via Benzinga

    Performance

    YTD
    -17.59%
    -17.59%
    1 Month
    +19.28%
    +19.28%
    3 Month
    +40.24%
    +40.24%
    6 Month
    -6.60%
    -6.60%
    1 Year
    -3.85%
    -3.85%

    More News

    Read More
    DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inari
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    NARI Investors Have Opportunity to Lead Inari Medical, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Inari Medical, Inc. (NARI)
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    NARI Investors Have Opportunity to Lead Inari Medical, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    NARI Investors Have the Opportunity to Lead Inari Medical, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    INARI MEDICAL 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Inari Medical, Inc. - NARI
    From Kahn Swick & Foti, LLC
    Via Business Wire
    NARI Investors Have Opportunity to Lead Inari Medical, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    NARI Investors Have the Opportunity to Lead Inari Medical, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    Inari Medical, Inc. INVESTOR ALERT: Kirby McInerney LLP Alerts Inari Medical, Inc. Investors of Looming Lead Plaintiff Deadline in Class Action Lawsuit
    From Kirby McInerney LLP
    Via Business Wire
    ROSEN, A LEADING NATIONAL FIRM, Encourages Inari Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NARI
    From The Rosen Law Firm PA
    Via GlobeNewswire
    NARI Investors Have Opportunity to Lead Inari Medical, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sprout Social, Inari, UnitedHealth, and Vestis and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Inari Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NARI
    From The Rosen Law Firm PA
    Via GlobeNewswire
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Harbor Diversified, Altimmune, Sprout Social, and Inari and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    NARI Investors Have Opportunity to Lead Inari Medical, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Inari Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NARI
    From The Rosen Law Firm PA
    Via GlobeNewswire
    NARI CLASS ACTION: Contact Robbins LLP for Information About the Class Action Against Inari Medical, Inc.
    From Robbins LLP
    Via GlobeNewswire
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Harbor Diversified, Altimmune, Sprout Social, and Inari and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    INARI MEDICAL, INC. (NASDAQ: NARI) INVESTOR ALERT: Bernstein Liebhard LLP Announces That A New Case Expanding the Class Period Has Been Filed Against Inari Medical, Inc.
    From Bernstein Liebhard LLP
    Via GlobeNewswire
    NARI Investors Have Opportunity to Lead Inari Medical, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sprout Social, Inari, UnitedHealth, and Vestis and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    INARI MEDICAL, INC. (NASDAQ: NARI) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Inari Medical, Inc.
    From Bernstein Liebhard LLP
    Via GlobeNewswire
    NARI Investors Have Opportunity to Lead Inari Medical, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.